|
Name |
1,2-Bis(p-(cis-styryl)phenyl)-trans-ethylene
|
| Molecular Formula | C30H24 | |
| IUPAC Name* |
1-[(Z)-2-phenylethenyl]-4-[(E)-2-[4-[(Z)-2-phenylethenyl]phenyl]ethenyl]benzene
|
|
| SMILES |
C1=CC=C(C=C1)/C=C\C2=CC=C(C=C2)/C=C/C3=CC=C(C=C3)/C=C\C4=CC=CC=C4
|
|
| InChI |
InChI=1S/C30H24/c1-3-7-25(8-4-1)11-13-27-15-19-29(20-16-27)23-24-30-21-17-28(18-22-30)14-12-26-9-5-2-6-10-26/h1-24H/b13-11-,14-12-,24-23+
|
|
| InChIKey |
DXQFGTYOUGMXMH-JFSXGQESSA-N
|
|
| Synonyms |
(E)-4,4'-Bis[(Z)-styryl]stilbene; 1,2-Bis(p-(cis-styryl)phenyl)-trans-ethylene; 1-[(Z)-2-Phenylethenyl]-4-((E)-2-(4-[(Z)-2-phenylethenyl]phenyl)ethenyl)benzene #
|
|
| CAS | NA | |
| PubChem CID | 5379644 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 384.5 | ALogp: | 9.3 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 30 | QED Weighted: | 0.277 |
| Caco-2 Permeability: | -4.948 | MDCK Permeability: | 0.00000920 |
| Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.005 |
| Human Intestinal Absorption (HIA): | 0.11 | 20% Bioavailability (F20%): | 0.987 |
| 30% Bioavailability (F30%): | 0.278 |
| Blood-Brain-Barrier Penetration (BBB): | 0.079 | Plasma Protein Binding (PPB): | 101.62% |
| Volume Distribution (VD): | 0.251 | Fu: | 0.41% |
| CYP1A2-inhibitor: | 0.758 | CYP1A2-substrate: | 0.063 |
| CYP2C19-inhibitor: | 0.235 | CYP2C19-substrate: | 0.062 |
| CYP2C9-inhibitor: | 0.098 | CYP2C9-substrate: | 0.001 |
| CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.031 |
| CYP3A4-inhibitor: | 0.174 | CYP3A4-substrate: | 0.411 |
| Clearance (CL): | 10.116 | Half-life (T1/2): | 0.063 |
| hERG Blockers: | 0.184 | Human Hepatotoxicity (H-HT): | 0.438 |
| Drug-inuced Liver Injury (DILI): | 0.977 | AMES Toxicity: | 0.89 |
| Rat Oral Acute Toxicity: | 0.248 | Maximum Recommended Daily Dose: | 0.368 |
| Skin Sensitization: | 0.877 | Carcinogencity: | 0.799 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.931 |
| Respiratory Toxicity: | 0.006 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000801 | ![]() |
0.396 | D00HPK | ![]() |
0.348 | ||
| ENC001456 | ![]() |
0.384 | D0AA2D | ![]() |
0.339 | ||
| ENC000894 | ![]() |
0.339 | D0Q3YO | ![]() |
0.328 | ||
| ENC001018 | ![]() |
0.330 | D09GOS | ![]() |
0.312 | ||
| ENC001523 | ![]() |
0.324 | D01VMO | ![]() |
0.307 | ||
| ENC005492 | ![]() |
0.318 | D05CEU | ![]() |
0.299 | ||
| ENC001737 | ![]() |
0.315 | D02CTS | ![]() |
0.290 | ||
| ENC001428 | ![]() |
0.311 | D07KSG | ![]() |
0.286 | ||
| ENC000891 | ![]() |
0.295 | D0U3ED | ![]() |
0.280 | ||
| ENC001402 | ![]() |
0.293 | D0VU2X | ![]() |
0.280 | ||